These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32678982)

  • 1. A Polymorphism at the microRNA Binding Site in the 3' Untranslated Region of
    Sha Z; Lai R; Zhang X; Zhao Y; Wu J; Geng C; Guo Z
    DNA Cell Biol; 2020 Oct; 39(10):1886-1894. PubMed ID: 32678982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma.
    Xie Y; Diao L; Zhang L; Liu C; Xu Z; Liu S
    Gene; 2014 Apr; 539(2):198-202. PubMed ID: 24530479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma.
    Campayo M; Navarro A; Viñolas N; Tejero R; Muñoz C; Diaz T; Marrades R; Cabanas ML; Gimferrer JM; Gascon P; Ramirez J; Monzo M
    PLoS One; 2011; 6(7):e22509. PubMed ID: 21799879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism at the microRNA binding site in the 3'-untranslated region of
    Wang C; Zhao Y; Ming Y; Zhao S; Guo Z
    Exp Ther Med; 2016 Sep; 12(3):1867-1872. PubMed ID: 27602096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation.
    de Larrea CF; Navarro A; Tejero R; Tovar N; Díaz T; Cibeira MT; Rosiñol L; Ferrer G; Rovira M; Rozman M; Monzó M; Bladé J
    Clin Cancer Res; 2012 Jul; 18(13):3697-704. PubMed ID: 22539802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness.
    Nanashima N; Horie K; Yamada T; Shimizu T; Tsuchida S
    Oncol Rep; 2017 May; 37(5):2964-2970. PubMed ID: 28405679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC.
    Robles AI; Ryan BM
    Ann Oncol; 2016 Feb; 27(2):360-1. PubMed ID: 26578733
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to the letter to the editor 'KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC' by Robles et al.
    Lee SY; Choi JE; Park JY
    Ann Oncol; 2016 Feb; 27(2):361-3. PubMed ID: 26578724
    [No Abstract]   [Full Text] [Related]  

  • 10. A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival.
    Yang B; Liu C; Diao L; Wang C; Guo Z
    Cancer Genet; 2014 Apr; 207(4):141-6. PubMed ID: 24831772
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang K; Liang Y; Zhang W; Zeng N; Tang S; Tian R
    DNA Cell Biol; 2021 Oct; 40(10):1290-1297. PubMed ID: 34591651
    [No Abstract]   [Full Text] [Related]  

  • 12. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
    Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
    Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma.
    Peng C; Guo Z; Wu X; Zhang XL
    Onco Targets Ther; 2015; 8():2075-9. PubMed ID: 26309413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
    Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
    Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Moazzeni H; Najafi A; Khani M
    Mol Cell Probes; 2017 Aug; 34():45-52. PubMed ID: 28546132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis.
    Zhou L; Dong S; Deng Y; Yang P; Zheng Y; Yao L; Zhang M; Yang S; Wu Y; Zhai Z; Li N; Kang H; Dai Z
    Mol Ther Nucleic Acids; 2019 Dec; 18():56-65. PubMed ID: 31525662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification.
    Zhang L; Liu Y; Song F; Zheng H; Hu L; Lu H; Liu P; Hao X; Zhang W; Chen K
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13653-8. PubMed ID: 21810988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.